NETRIS PHARMA SAS

Description

NETRIS Pharma develops first-in-class therapeutics targeting Netrin-1 to overcome resistance in oncology, providing treatments to patients facing chemotherapy, targeted therapy, and immunotherapy resistance.

Related

• RS Research Inc.Develops polymer-drug conjugate delivery platforms for targeted chemotherapy and theranostics, used to improve therapeutic index for…
• ONK TherapeuticsONK Therapeutics develops ready-made natural killer cell therapies.
• H. Lee Moffitt Cancer CenterNCI-designated comprehensive cancer center. Significant translational research in immunotherapy, cellular therapy (CAR-T), and AI-driven…
• ENERSENSBuilds silica aerogel thermal barriers combining ultra-thin insulation and certified fire resistance for batteries, aerospace and defense…
• TareBioDevelops vaccines intended for cancer and infectious diseases, addressing needs in oncology and infection prevention or treatment for…
• ARTHEX BIOTECH S.L.Develops RNA-based therapeutics, specifically anti-miR oligonucleotides for myotonic dystrophy and other diseases, used by researchers and…
• OrixhaOrixha develops a proprietary Total Liquid Ventilation technology called LuncoLive for intensivists and critical care professionals to…
• THERAPANACEABuilds AI-driven oncology software and platforms for clinical teams and cancer centers to support segmentation, planning, and adaptive…
• Faron Pharmaceuticals Ltd.Develops immunotherapies that leverage patients' immune systems for cancer treatment, serving clinical researchers and healthcare providers…
• CarTheraCarthera designs ultrasound-based medical devices that temporarily open the blood–brain barrier for treating glioblastoma and other severe…
• Camurus ABDevelops innovative, long-acting treatments for severe and chronic diseases; used by patients and healthcare systems addressing unmet…
• LabGenius TherapeuticsLabGenius Therapeutics develops EVA, an automated platform for discovering and optimizing complex therapeutic antibodies.